Penumbra Medical - Bathi resik saben saham sajrone 12 wulan pungkasan PEN

Penumbra, Inc. (PEN) generates revenue through the implementation of advanced systems for minimally invasive clot removal and vascular therapy. The EPS YoY TTM growth trajectory visualizes profit dynamics, where the value -5.50 captures the metric level. However, international expansion is limited by certification complexities and component logistics. Business stability relies on demand in the stroke segment and the high margins of specialized medical devices.
Penumbra - rincian analitis lan metrik utama (PEN)

Year-over-year EPS growth (TTM) measures the rate of change in net income per share over a rolling twelve-month period. For Penumbra, Inc. (PEN), this metric reflects the efficiency of implementing innovative thrombectomy systems against the costs of greening production and minimizing plastic use. By analyzing the history of year-over-year EPS dynamics (over 12 months), an investor can see the actual acceleration of the business. A sharp spike in the line signals the risk of overpaying for the asset.